JUL 28, 2020 2:33 PM PDT

Neonatal Origins of Chronic Inflammatory Disease

WRITTEN BY: Kara Marker

From birth, our genes write the story of our lives. For many people who develop chronic immune and inflammatory diseases at some point from childhood to adulthood, the genetic changes that promote disease may be detectable as a newborn.

Researchers from a new study wanted to do just that: study newborn immune cells to see how specific genetic variants may predict chronic disease. They collected cord blood samples from more than 100 Australian newborns already enrolled in the Childhood Asthma Study. Studying immune cells from those samples, researchers challenged the cells with various stimuli intended to prompt a disease response. They observed how certain genetic variants affected genetic expression that ultimately changed how the stimuli influenced the cells. Was there overlap between their observations and known genetic activity associated with chronic immune conditions? Yes.

Researchers discovered thousands of genetic variants affecting gene expression involved in various immune-related conditions. Chronic immune and inflammatory diseases are known to have a polygenic influence, meaning that not just a single gene was responsible for the disease. Many variants in different genomic locations play different roles in how disease affects the body over time.

The study is part of a larger mission to develop a disease prediction tool using “polygenic risk scores” with information gathered from observations like these. With such a tool, chronic immune and inflammatory diseases like type 1 diabetes, rheumatoid arthritis, celiac disease, and multiple sclerosis, many of which don’t manifest symptoms until later in life, could be predicted as early as infancy. And with prediction comes the possibility for therapeutic intervention to prevent or at least slow progression of disease.

"To date, similar studies have only been conducted in adult immune cells,” explained lead author Qinqin Huang. “Given the huge difference between neonatal and adult immunity, it is not surprising to see many signals that were unique to newborns."

Unique genomic compositions are at least partially responsible for changing genetic function, so much so that it eventually leads to disease, often beginning in childhood and coming to full fruition in adulthood.

Sources: Baker Heart and Diabetes Institute, Nature Communications

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 12, 2021
Immunology
Illuminating the COVID-19 Disease Profile Puzzle
MAY 12, 2021
Illuminating the COVID-19 Disease Profile Puzzle
Teams of science experts from numerous disciplines have been collecting data on SARS-CoV-2 for over a year to understand ...
MAY 11, 2021
Genetics & Genomics
Gene Therapy Trial for Severe Immune Disorder is Successful
MAY 11, 2021
Gene Therapy Trial for Severe Immune Disorder is Successful
Severe combined immunodeficiency (SCID), which virtually eliminates a patient's immune system, and severely affects thei ...
MAY 22, 2021
Drug Discovery & Development
Drug Combo Treats 86% of Patients with Gout
MAY 22, 2021
Drug Combo Treats 86% of Patients with Gout
Researchers at the University of Michigan have found that a combination of two drugs is twice as effective as current tr ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
JUN 03, 2021
Immunology
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
JUN 03, 2021
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
Nanobodies are small fragments of monoclonal antibodies that from a therapeutic perspective are more stable and cheaper ...
JUN 29, 2021
Immunology
The Heartbreaking Nature of COVID Revealed
JUN 29, 2021
The Heartbreaking Nature of COVID Revealed
Researchers at the Washington University School are getting to the root of heart damage resulting from COVID-19 infectio ...
Loading Comments...